Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
暂无分享,去创建一个
Kurt A Brorson | Erik K Read | Scott Lute | Cyrus Agarabi | David Awotwe-Otoo | M. Khan | D. Awotwe-Otoo | C. Agarabi | E. Read | S. Lute | K. Brorson | Mansoor A Khan
[1] Scott Lute,et al. Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody. , 2013, International journal of pharmaceutics.
[2] Brendan Fish,et al. Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies , 2007, Biotechnology & genetic engineering reviews.
[3] Xiaolin Tang,et al. Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice , 2004, Pharmaceutical Research.
[4] M. Manning,et al. Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.
[5] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[6] J. Casas-Finet,et al. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies. , 2013, Journal of pharmaceutical sciences.
[7] A. Casadevall,et al. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure. , 2010, Molecular immunology.
[8] P. Deluca,et al. Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A. , 1988, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[9] B. Chang,et al. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.
[10] Alain Balland,et al. Characterization of nonenzymatic glycation on a monoclonal antibody. , 2007, Analytical chemistry.
[11] Robert W. Payne,et al. Structure, stability, and mobility of a lyophilized IgG1 monoclonal antibody as determined using second-derivative infrared spectroscopy. , 2012, Journal of pharmaceutical sciences.
[12] Ron Taticek,et al. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior. , 2008, Analytical biochemistry.
[13] J. Carpenter,et al. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. , 2001, Journal of pharmaceutical sciences.
[14] A. Vermeer,et al. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.
[15] J H Crowe,et al. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying , 1995, Applied and environmental microbiology.
[16] Wolfgang Friess,et al. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] Margaret Ricci,et al. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. , 2007, Journal of pharmaceutical sciences.
[18] R. Borchardt,et al. Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state. , 1996, Journal of pharmaceutical sciences.
[19] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[20] Steven L Nail,et al. Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. , 2011, Journal of pharmaceutical sciences.
[21] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[22] C. Quan,et al. Susceptibility of rhDNase I to glycation in the dry-powder state. , 1999, Analytical chemistry.
[23] Hanns-Christian Mahler,et al. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] Michael J. Pikal,et al. Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.
[25] J. Carpenter,et al. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. , 2001, Journal of pharmaceutical sciences.
[26] J. Casas-Finet,et al. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies. , 2013, Journal of pharmaceutical sciences.
[27] D. Hambly,et al. The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies. , 2009, Journal of pharmaceutical sciences.
[28] M. N. Gupta,et al. Freeze‐drying of proteins: some emerging concerns , 2004, Biotechnology and applied biochemistry.